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Abstract
The severity of periodontitis on patients with type 2 Diabetes Mellitus patients was strongly thought caused
by decreasing of leukocytes function such as monoctyes and neutrophils. In our previous research it was
found that calprotectin (MRP8/MRP14) level in leukocytes of periodontitis patients with type 2 DM was
higher than periodontitis in non DM. The aim of this study was to determine calprotectin (MRP8/MRP14)
mRNA expression in human monocytes of periodontitis patients with type 2 DM and without DM. Monocytes
were isolated from the peripheral blood of periodontitis patients with uncontrolled type 2 DM, controlled
type 2 DM, and non DM. The expression of total RNA calprotectin (MRP8 and MRP14) were detected by RT-
PCR using GAPDH as the innate control. It was observed that the value of MRP8/MRP14 mRNA expression
DM patients were higher than non DM, and the highly significant increase expression (p<0.05) was on the
uncontrolled type 2 DM. The basal level of MRP8/MRP14 expression increased in monocyte of periodontitis
and type 2 DM patients compared with non diabetes subjects. It was suggested that high basal level MRP8/
MRP14 has role in the regulation of severity periodontitis with diabetes mellitus.
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1. Introduction
Diabetes mellitus is a common and growing global
health problem. It is highly prevalent in Asian
populations and about 90 percent of diabetes
mellitus is type 2 (Non Insulin Dependent Diabetes
Mellitus/NIDDM). In Indonesia, the incidence rate for
those who are above 15 years old in Indonesia was
1,2-2,3% and it has tendency to increase.1 Among
the late complications assosiated to the diabetes
mellitus, periodontitis has been highlighted, and it
can be more severe and refractory to treatment than
in healthy subjects.2 Meanwhile, periodontitis is still
a problem in the field of dentistry and ranked
number-eight of the 10 major outpatients diseases
at the General Hospital in Indonesia3
The incidence of periodontitis increases, more
frequent and severe in diabetic patients with more
advanced systemic complications, and the increased
susceptability does not correlate with increased
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levels of dental plaque or calculus.4 The severity of
periodotitis in diabetic patient was strongly thought
caused by decreasing of leukocytes function such as
monocytes and neutrophils.  As one of very frequent
complication of diabetes mellitus, periodontitis was
known to be caused by immune response
disturbances such as; decreasing of chemotaxis,
adherence, and phagocytosis of neutrophils.5
Calprotectin is a calcium binding protein that has
a molecular weight of 36.5 kDa, belongs to the S-
100 protein family and its detected in monocytes,
neutrophils, and epithelial cells, being composed of
two subunits macrophage migration inhibitory
factor-related protectin 8 and 14 (MRP8 and
MRP14).6.7 It is known that calprotectin plays an
important role in the innate immunitiy, and its level
is markedly increase in plasma, feces, and synovial
fluid from patients with infections and inflamatory
diseases8. Calprotectin level in gingival crevicular fluid
(GCF) of periodontitis patients was significanly higher
than healthy subjects and it was  detected in gingival
tissue only from the periodontitis patients.1,2
It was also known that calprotectin has the
extracellular function, including antibacterial,
chemotactic factor, and inhibition binding of
pathogenic bacteria to the epithelial cell, suggest that
calprotectin may play a role in the immune response
mechanism of periodontitis9. However, the exact role
of calprotectin in periodontitis patient with diabetes
mellitus is unclear.  In our previous research, it was
found that the calprotectin level in serum of
periodontitis patients with type 2 diabetes mellitus
is higher than periodontitis of non DM patients10, and
the basal level of calprotectin mRNA MRP8/MRP14
expression increased in neutrophils of periodontitis
patients with type 2 diabetes mellitus.11
In the present study, we determine calprotectin
mRNA (MRP8/MRP14) expression in human mon
ocytes of periodontitis patients with type 2 diabetes
mellitus, comparing between diabetic and non
diabetic mRNA. The aim of this study was to
determine calprotectin expression in human
neutrophils of periodontitis patients with type 2
diabetes mellitus, both controlled and uncontrolled
hyperglycemic, compare with non diabetic subject.
2. Materials and Methods
2.1. Monocytes preparation and isolation
First peripheral blood was collected from 36
periodontitis subjects with and without type 2
diabetes mellitus following informed consent to
participate in the study. The diabetic subjects were
outpatients who came to the Dr. Sardjito General
Hospital Yogyakarta, whereas periodonitis and non
diabetic patients were obtained from the Dental
Hospital of the Faculty of Dentistry, Gadjah Mada
University, Yogyakarta. Monocytes were separated
from heparinized blood by density gradient
centrifugation using Histopaque®-1077 (Sigma-
Aldrich), and these cells were collected in eppendorf
tube as samples for RNA determination.
Monocytes from periodontitis subjects with
unconrolled DM, controlled DM, and non DM were
isolated from its RNA using Trizol® Reagent
(Invitrogen) according to the manufacturer’s
protocol. Into pellet cell 1 ml Trizol Reagent was
added, suspensed with injection spuit and incubated
in room temperature for 5 minutes. Chloroform was
added 20 µl and mixed by hands, then centrifugated
12.000 g for 15 minutes in temperature 4oC.  Aqueous
phase was transferred by mixing with fresh tube and
the RNA was precipitated from the aqueous phase
by mixing with 500 µl isoprophyl alcohol. RNA
samples were incubated at  room temperature  for
10 minutes and then centrifuged at 12.000 x g for 10
minutes at 4oC. The RNA pellet was washed with 1
ml ethanol 75% and mixed the sample by vortexing
and centrifugation at 7.500 x g for 5 minutes at 4oC.
The RNA pellet was briefly dried with vacuum dry
for 3 minutes and redisolving  the RNA in 30 µl RNAse
free water.
2.2. Determination RNA calprotectin by
RT-PCR.
Calprotectin RNA (MRP8 and MRP14) expression was
determined by Reverse Transcriptase Polymerase
Chain Reaction (RT-PCR) according to manufacturer’s
procedure.  Two steps RT-PCR procedures were used,
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first step was cDNA syntesis  from RNA samples and
continued with PCR procedure as the second step.
Master mix for cDNA synthesis was: 10 x Reaction
Buffer, 25mM MgCl2, Deoxy Nucleotid Mix, Primer
pd (T)6, RNAse Inhibitor, and AMV RT. To determine
mRNA calprotectin, we amplified cDNA samples and
PCR Primers for Calprotectin (Table 1) by polymerase
chain reaction (PCR).  PCR products were then
checked by electrophoresis to measured band
intesity of the MRP8 and MRP14 Calprotectin mRNA.
The intensity of each band was normally done by
comparing it with the GAPDH band. The expression
of calprotectin (MRP18 and MRP14) mRNA was
represented as the intensitiy of bands that were
checked by  thin layer  chromatography (TLC) and
represented as mean relative total RNA ± SD from
the samples.
Table 1. PCR Primers in this study
Figure 1. Band position of MRP8, MRP14, GAPDH
primers comparing with 100bp DNA ladder. All
primers were in the correct positions base on the
values of base pairs (bp).
To determine the influence of hyperglycemic
condition on diabetic subjects to MRP8 and MRP14
expression in human monocytes of periodontitis
patients, the expression of MRP8/14 mRNA was
examined. When monocytes were isolated from
diabetic and non diabetic subjects, the expression
of MRP8 mRNA was significantly higher than MRP14
mRNA. The intensity of bands markedly increased in
uncontrolled DM patient (Fig.2).
Oligonucleotide Sequence Product
MRP8 sense 5:-GCTGGAGAAAGCCTTGAACTC-3' 232 bp
MRP8 antisense 5 -CCACGCCCATCTTrATCACCA-3'
MRP 14 sense 5'-TCGCAGCTGGAACGCAACATA-3' 213 bp
MRP14 antisense 5'-AGCTCAGCTGC TTGTCTGCAT-3'
GADPH sense 5'-TCCACACC CTGTTGCTGTA-3' 558 bp
GAPDH antisense 5'-ACCACAGTCCATGCCATCAC-3'
2.3. Statistical analysis
Statistical analysis was performed by One Way
ANOVA for the samples. Values of p<0.05 were
accepted as statistically significant.  Results were
expressed as the mean±SD and statistical analysis.
3. Results
The band position of calprotectin mRNA (MRP8 and
MRP14) and also GAPDH were in correct position
based on the base pairs (bp) values of GAPDH (558
bp), MRP8 (232 bp), and MRP14 (213 bp) as
mentioned by the manufacturer’s protocol. The
suitable position of all oligonucelotides compared
with the  100 bp DNA ladder were shown on Figure 1.
Figure 2. MRP8/MRP14  mRNA  expression of
human monocytes from diabetic and non diabetic
subjects.  The expression of mRNA was determined
in 1mg RNA from resting neutrophils by RT-PCR
using MRP8, MRP14, and GAPDH primers.
Both MRP8 and MPR14 mRNA expression in
periodontitis patients with type 2 DM  were higher
than non DM patients, while the highest expression
of mRNA MRP8/MRP14  was in uncontrolled DM
(Table 2); suggesting that MRP8/MRP14 mRNA has
importance role for severity of periodontitis in
diabetic patient. The result of One Way ANOVA (Table
3) showed that the expression of MRP8 and MRP 14
in human monocytes of periodontitis patients were
significantly influenced by diabtetics status (p<0.05).
The LSD test showed significant difference of the
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means of non diabetic and uncontrolled diabetic,
controlled and uncontrolled diabetic, whereas the
means of non diabetic and controlled diabetic were
not significantly different (Table 4).
Table 2.  Mean and standard deviation of expression
of monocyte MRP8/MRP14 non-diabetic patients
with periodontitis, periodontitis with controlled DM
and uncontrolled DM.
4. Discussion
Periodontitis is always found among diabetic
patients, and severity of  periodontitis on diabetic is
more progressive than non diabetic patients although
the bacteria that caused were the same.12.13 Some
studies show that increasing severity of diabetic
periodontitis is mainly influenced by the immune
system disorders.14.15 The existence of vascular
changes in the form of capillary basal membrane
thickening due hyperglicemic conditions, also causes
disruption of the nutrients and the migration of
immune cells into the periodontal tissue.12
Calprotectin (MRP8 /MRP14) is cytosolic protein that
has important functions as chemotactic factor
associated with the activation of monocytes and
neutrophils, and accumulation of cells of innate
immunity in areas of inflammation as well as an
antibacterial protein. It also has adhesion, regulation,
migration activities of monocytes and neutrophils,
and is recently known to have important role in body
immunity an a natural immune system of periodontal
tissues.9.22
This study identified that calprotectin mRNA
(MRP8 /MRP14) expression in monocytes of
periodontitis with type 2 diabetes mellitus was
different from periodontitis in non diabetes patients,
and the highest calprotectin expression was on
uncontrolled type 2 diabetes mellitus compared with
controlled diabetes and non diabetes (Table 2). The
different expressions of calprotectin from human
monocytes on diabetic and non diabetic patients
strongly suspect correlation with impairment of
immune cell function, especially innate immunity
cells such as monocytes and neutrophils. Some
authors mentioned that this impairment of function
including chemotaxis, diapedesis, and phagocytosis
of neutrophils,17  but which one of those functions
that was very dominant to cause  severity of diabetic
periodontitis remains unclear.  Our result showed
that calprotectin MRP8 /MRP14 mRNA  expression
in periodontitis patients with diabetes mellitus was
different with non diabetic subjects, whi le
calprotectin has been well known as a chemotactic
factor.18.19 The previous study demonstrated that
diabetics patients with severe periodontitis
depressed PMN (neutrophils) chemotaxis compared
Table 4. Statistical results of LSD test from MRP8/
MRP14 expression on monocytes  periodontitis
non-diabetic patients, periodontitis with controlled
DM,  and periodontits with uncontrolled DM.
Groups P
MRP8 MRP14
Non DM-controlled DM 0.359 0.721
Non DM-uncontrolled DM 0.009** 0.015*
Controlled DM-uncontrolled DM 0.075 0.034*
Table 3. Oneway ANOVA results on the expression
of calprotectin MRP8/MRP14 in monocytes of
periodontitis non-diabetic patients, periodontitis
with controlled DM and periodontitis with
uncontrolled DM.
Group Number of Mean ± SD
sampel
MRP8 MRP14
Periodontitis non 12 0.939 ± 0.3 85 0234 ± 0.149
diabetic
Periodontitis 12 1.154 ± 0.461 0.278 ± 0.172
controlled diabetic
Periodontitis 12 1.579 ± 0.774 0.549 ± 0.469
uncontrolled diabetic
Expression of MRP8 RNA monocytes
Sum of Df Means F p
squares square
Between groups 2.547 2 1.274 3.972 0.028*
Within groups 10.581 33 0.321
Total 13.129 35
Expression of MRP8 RNA monocytes
Between groups 0.696 2 0.348 3.890 0.030*
Within groups 2.951 33 0.089
Total 3.647 35
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to those with periodontitis on non diabetic subjects
with severe or mild periodontitis.4
The results of the study also identified that the
highest calprotectin MRP8/14 mRNA expression were
in periodontitis patients with uncontrolled type 2
diabetes mellitus.  It may be caused by pro-
inflammatory cytokines that markedly increased in
blood of uncontrolled diabetes mellitus patient. Pro-
inflammatory cytokines such as TNF-alfa and IL1-beta
were present  in large amount in blood circulating
diabetic patients, and it was reported that its level is
higher in uncontrolled DM than controlled DM.20.21
These cytokines, both TNF-alfa and IL-1beta,  are
found in the circulating peripheral blood and its level
is increased in several inflammatory diseases,
including periodontitis. In the previous study, it was
reported that expression of MRP8 /MRP14 was
increased in monocytes by several factors and
compounds including TNF-alfa, and it was also known
that this cytokine can stimulate calprotectin
expression in human monocytes and neutrophils.22.23
MRP8 /MRP14 is found predominantly in a
cytosolic location in both monocytes and
neutrophils, it represents about 45-60% of the total
neutrophils cytosolic protein.6.24  After activations of
neutrophils, MRP8 and MRP14 are released into the
extracellueler compartment via tubulin dependent
pathway, where they are known to promote the
adhesion of neutrophlis and monocytes to
endothelium.24 Previously, we identified high basal
level concentration of calprotectin intracellular in
monocyte and neutrophils that was determined by
ELISA kit (unpublished data). We also found the
increasing basal level of calprotectin in serum of
periodontitis patients with type 2 diabetes mellitus.10
In this study, we found the same pattern of increasing
calprotectin mRNA expression in uncontrolled type2
diabetic patients. It can be understood, because
uncontrolled diabetic patients have persistently high
concentration of TNF-alfa in their blood circulation,
whereas TNF-alfa potentially stimulates monocytes
to increase  MRP8 /MRP14 mRNA expression and
calprotectin production.
Our conclusion is the basal level of calprotectin
mRNA MRP8 /MRP14 expression increased in
monocytes of periodontitis patient with type 2 DM
compared with non diabetes subjects. It was
suggested that high basal level of calprotectin mRNA
has role in the regulation of severity of periodontitis
with diabetes mellitus. Therefore, MRP8 /MRP14
may be a potentially selective novel biomarker for
early symptom of diabetic periodontitis.
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